Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Mitral valve incompetence? 145 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 145 reports of Mitral valve incompetence have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.2% of all adverse event reports for DOXORUBICIN.

145
Reports of Mitral valve incompetence with DOXORUBICIN
0.2%
of all DOXORUBICIN reports
8
Deaths
88
Hospitalizations

How Dangerous Is Mitral valve incompetence From DOXORUBICIN?

Of the 145 reports, 8 (5.5%) resulted in death, 88 (60.7%) required hospitalization, and 39 (26.9%) were considered life-threatening.

Is Mitral valve incompetence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 145 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Mitral valve incompetence?

SACUBITRIL\VALSARTAN (437) BISOPROLOL (370) ASPIRIN (282) FENFLURAMINE (276) PANTOPRAZOLE (264) FUROSEMIDE (252) ATORVASTATIN (222) ADALIMUMAB (212) VALSARTAN (185) AMLODIPINE (178)

Which DOXORUBICIN Alternatives Have Lower Mitral valve incompetence Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Mitral valve incompetence Reports All Drugs Causing Mitral valve incompetence DOXORUBICIN Demographics